142 related articles for article (PubMed ID: 16702337)
41. Low-fat diets do not lower plasma cholesterol levels in healthy men compared to high-fat diets with similar fatty acid composition at constant caloric intake.
Nelson GJ; Schmidt PC; Kelley DS
Lipids; 1995 Nov; 30(11):969-76. PubMed ID: 8569436
[TBL] [Abstract][Full Text] [Related]
42. Replacing dietary palmitic acid with elaidic acid (t-C18:1 delta9) depresses HDL and increases CETP activity in cebus monkeys.
Khosla P; Hajri T; Pronczuk A; Hayes KC
J Nutr; 1997 Mar; 127(3):531S-536S. PubMed ID: 9082041
[TBL] [Abstract][Full Text] [Related]
43. Effects of regulatory peptides on the stress-induced changes of lipid metabolism in experimental animals.
Solin AV; Korozin VI; Lyashev YD
Bull Exp Biol Med; 2013 Jul; 155(3):324-6. PubMed ID: 24137594
[TBL] [Abstract][Full Text] [Related]
44. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
[TBL] [Abstract][Full Text] [Related]
45. Impact of grape pomace consumption on the blood lipid profile and liver genes associated with lipid metabolism of young rats.
Yu J; Bansode RR; Smith IN; Hurley SL
Food Funct; 2017 Aug; 8(8):2731-2738. PubMed ID: 28725902
[TBL] [Abstract][Full Text] [Related]
46. A comprehensive metabolic profiling of the metabolically healthy obesity phenotype.
Telle-Hansen VH; Christensen JJ; Formo GA; Holven KB; Ulven SM
Lipids Health Dis; 2020 May; 19(1):90. PubMed ID: 32386512
[TBL] [Abstract][Full Text] [Related]
47. The evolution of plasma cholesterol: direct utility or a "spandrel" of hepatic lipid metabolism?
Babin PJ; Gibbons GF
Prog Lipid Res; 2009 Mar; 48(2):73-91. PubMed ID: 19049814
[TBL] [Abstract][Full Text] [Related]
48. The effect of various phospholipids on plasma lipoproteins and liver lipids in hypercholesterolemic rats.
Iwata T; Kimura Y; Tsutsumi K; Furukawa Y; Kimura S
J Nutr Sci Vitaminol (Tokyo); 1993 Feb; 39(1):63-71. PubMed ID: 8509902
[TBL] [Abstract][Full Text] [Related]
49. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
Heimberg M; Olubadewo JO; Wilcox HG
Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
[TBL] [Abstract][Full Text] [Related]
50. Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome.
Olson EJ; Pearce GL; Jones NP; Sprecher DL
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2289-94. PubMed ID: 22814748
[TBL] [Abstract][Full Text] [Related]
51. Pathophysiology of Diabetic Dyslipidemia.
Hirano T
J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
[TBL] [Abstract][Full Text] [Related]
52. LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?
Hewing B; Landmesser U
Curr Cardiol Rep; 2015 Jul; 17(7):610. PubMed ID: 26031673
[TBL] [Abstract][Full Text] [Related]
53. High dietary cholesterol and ovariectomy in rats repress gene expression of key markers of VLDL and bile acid metabolism in liver.
Farahnak Z; Côté I; Ngo Sock ET; Lavoie JM
Lipids Health Dis; 2015 Oct; 14():125. PubMed ID: 26453540
[TBL] [Abstract][Full Text] [Related]
54. Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats.
Kamal-Eldin A; Frank J; Razdan A; Tengblad S; Basu S; Vessby B
Lipids; 2000 Apr; 35(4):427-35. PubMed ID: 10858028
[TBL] [Abstract][Full Text] [Related]
55. Methionine deficiency in rats fed soy protein induces hypercholesterolemia and potentiates lipoprotein susceptibility to peroxidation.
Moundras C; Rémésy C; Levrat MA; Demigné C
Metabolism; 1995 Sep; 44(9):1146-52. PubMed ID: 7666787
[TBL] [Abstract][Full Text] [Related]
56. The effect of dietary protein and sulfur amino acids on hepatic glutathione concentration and glutathione-dependent enzyme activities in the rat.
Bauman PF; Smith TK; Bray TM
Can J Physiol Pharmacol; 1988 Aug; 66(8):1048-52. PubMed ID: 3179838
[TBL] [Abstract][Full Text] [Related]
57. Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9.
van der Tuin SJ; Kühnast S; Berbée JF; Verschuren L; Pieterman EJ; Havekes LM; van der Hoorn JW; Rensen PC; Jukema JW; Princen HM; Willems van Dijk K; Wang Y
J Lipid Res; 2015 Nov; 56(11):2085-93. PubMed ID: 26342106
[TBL] [Abstract][Full Text] [Related]
58. Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed rats.
Wang D; Han J; Yu Y; Li X; Wang Y; Tian H; Guo S; Jin S; Luo T; Qin S
Exp Biol Med (Maywood); 2011 Sep; 236(9):1064-9. PubMed ID: 21856756
[TBL] [Abstract][Full Text] [Related]
59. The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism.
Wang Y; Zhang Y; Qian H; Lu J; Zhang Z; Min X; Lang M; Yang H; Wang N; Zhang P
PLoS One; 2013; 8(8):e72315. PubMed ID: 23951308
[TBL] [Abstract][Full Text] [Related]
60. Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.
al-Shurbaji A; Skorve J; Berge RK; Rudling M; Björkhem I; Berglund L
Arterioscler Thromb; 1993 Nov; 13(11):1580-6. PubMed ID: 8218098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
